PCM
DMTK

Parsifal Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Parsifal Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-220,713
Closed -$11.2M – 18
2021
Q1 		$11.2M Buy
+220,713
New +$11.5M 0.99% 17

Other funds holding DMTK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Parsifal Capital Management's DMTK Position: Q2 2021 in Review

Parsifal Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 220,713 shares — an estimated $11.2M sold.

Parsifal Capital Management first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $11.2M in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Parsifal Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Parsifal Capital Management sold 220,713 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $11.2M.
  • Parsifal Capital Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Parsifal Capital Management's DermTech, Inc. Common Stock position peaked at $11.2M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Parsifal Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.